Ginsenoside Rd ameliorated colitis by inducing p62-driven mitophagy-mediated NLRP3 inflammasome inactivation and upregulating of AMPK/ULK1 signaling pathway in DSS-induced murine colitis model [59]. The gene discussed is NLRP3; the disease is colitis.